Search
for
Sort by
Research 541–570 of 1000+
- Mayo Clinic office visit. Female-pattern hair loss. An interview with Rochelle Torgerson, M.D., Ph.D.
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Medikamentöse Therapie des benignen Prostatasyndroms
- Diseases of the skin. Drug ill effects on the skin.
- Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- 12. Cancer
- Long-term opioid ADR management in cancer patients
- Volume 1982, No. 4 February 26, 1982
- Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
- Farmácia da Boa Hora, Porto e nos Serviços Farmacêuticos do Hospital Lusíadas, Porto
- Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
- Drugs and Hair Loss
- Herbal Treatment for Dermatologic Disorders
- Hair loss due to methylphenidate use: A case study
- Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
- Association of melanoma and nonmelanoma skin cancer with antihypertensive drugs: A report from the Research on Adverse Drug events And Reports project
- أدوية الإقلاع عن التدخين
- Polycystic Ovary Syndrome (PCOS) - Hormonal Change In Reproductive Women
- Risk factors for intraoperative floppy iris syndrome: One year prospective study
- Finasteride/tamsulosin
- Editorial Comment
- A case of red lunulae after haematopoietic stem cell transplantation
- Acne and Systemic Disease
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- The spectrum of nephrocutaneous diseases and associations
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine